Long-term consequences of early developmental exposure to drugs of abuse may have deleterious effects on the proliferative plasticity of the brain. The purpose of this study was to examine the long-term effects of prenatal exposure to cocaine, using the IV route of administration and doses that mimic the peak arterial levels of cocaine use in humans, on the proliferative cell types of the subventricular zones (SVZ) in the adult (180 days-old) rat brain. Employing immunocytochemistry, the expression of GFAP + (type B cells) and nestin + (GFAP − ) (type C and A cells) staining was quantified in the subcallosal area of the SVZ. GFAP + expression was significantly different between the prenatal cocaine treated group and the vehicle (saline) control group. The prenatal cocaine treated group possessed significantly lower GFAP + expression relative to the vehicle control group, suggesting that prenatal cocaine exposure significantly reduced the expression of type B neural stem cells of the SVZ. In addition, there was a significant sex difference in nestin + expression with females showing approximately 8-13% higher nestin + expression compared to the males. More importantly, a significant prenatal treatment condition (prenatal cocaine, control) by sex interaction in nestin + expression was confirmed, indicating different effects of cocaine based on sex of the animal. Specifically, prenatal cocaine exposure eliminated the basal difference between the sexes. Collectively, the present findings suggest that prenatal exposure to cocaine, when delivered via a protocol designed to capture prominent features of recreational usage, can selectively alter the major proliferative cell types in the subcallosal area of the SVZ in an adult rat brain, and does so differently for males and females.
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Introduction
A high rate of drug use in the US is consistently found among our youth; for 8th, 10th, and 12th grade students, lifetime usage figures of any illicit drug in the 12 months preceding the survey were 19%, 36%, and 47% (Johnston et al., 2010) . In other words, just under half of American recent secondary school students have tried an illicit drug by the time they near high school graduation. In 2009, an estimated 21.8 million Americans aged 12 or older were current illicit drug users, meaning they had used an illicit drug during the month prior to the survey interview (SAMHSA, 2010) . This estimate represents 8.7% of the population aged 12 years-old or older. The rate of current illicit drug use among persons aged 12 or older in 2007 (8.7%) was higher than the rate in 2008 (8.0%). The population of young female drug users of childbearing age is of particular note. Among pregnant women aged 15-44 years, 4.5% used illicit drugs in the past month (SAMHSA, 2010) .
Additional troublesome data on the specific abuse of cocaine in the US is also available. Today, about one in seven young adults (14% in 2009) have tried cocaine, and 6% have tried it by their senior year of high school (i.e., by age 17 or 18). More than 1 in every 42 twelfth graders (2.4%) has tried crack. In the young adult sample, 1 in 28 (3.6%) has tried crack by age 29-30 (Johnston et al., 2010) . Presently, there are 1.6 million current cocaine users aged 12 or older, comprising 0.7% of the population. These estimates were similar to the number and rate in 2008 (1.9 million or 0.7%). Clearly, cocaine/crack use among adult and young women of childbearing age remains a significant societal concern, placing future generations at risk. Furthermore, the recent review of countries around the world has suggested high lifetime prevalence use of cocaine in Argentina (7.9%), Italy (6.6%), United Kingdom (6.5%), Chile (5.9%), and Ireland 5.3% (Degenhardt et al., 2011) ; the implication of cocaine abuse for future generations appears to be far more than a US health issue. Thus, comprehending the effects of prenatal drug exposure, such as cocaine/crack, on the development
